求助PDF
{"title":"Non-pharmacological approaches in gastroesophageal reflux disease: Evidence-based dietary and lifestyle interventions","authors":"Luisa Bertin , Federico Caldart , Edoardo Vincenzo Savarino","doi":"10.1016/j.bpg.2025.102083","DOIUrl":null,"url":null,"abstract":"<div><div>Gastroesophageal reflux disease (GERD) affects 18–28 % of Western populations, with 10–40 % experiencing refractory symptoms despite proton pump inhibitor therapy. We conducted a comprehensive narrative review of dietary interventions in GERD, analyzing studies that measured clinical efficacy through validated symptom scores (GERD-Q, RDQ) and objective reflux parameters (24-h pH-impedance monitoring, acid exposure time). We examined pathophysiological mechanisms, intervention efficacy, and clinical implementation strategies across diverse patient populations. Structured dietary interventions demonstrate clinically meaningful outcomes with robust mechanistic rationale. Low-carbohydrate approaches achieved significant reductions in esophageal acid exposure time (mean difference −2.83 %, 95 % CI: −4.554 to −1.114, p < 0.001), while systematic trigger food elimination protocols achieved 23 % improvement in GERD-Q scores, enabling 45 % of patients to discontinue pharmacological therapy. Plant-based dietary patterns showed remarkable protective effects with 50 % reduction in GERD prevalence (OR = 1.96, 95 % CI 1.22–3.17 for animal food consumption). Weight management interventions demonstrated exceptional efficacy in overweight patients, with GERD prevalence decreasing from 37 % to 15 % (p < 0.01) and 65 % achieving complete symptom resolution. Individual dietary trigger identification achieved high success rates with standardized protocols. Evidence-based dietary interventions offer clinically meaningful alternatives or adjuncts to pharmacological therapy. However, significant study heterogeneity and predominance of short-term trials limit definitive clinical recommendations. Future research should prioritize developing validated precision medicine algorithms integrating clinical phenotyping, genetic markers, and microbiome profiling to optimize personalized dietary prescriptions and investigate long-term sustainability of dietary modifications.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"79 ","pages":"Article 102083"},"PeriodicalIF":5.2000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best Practice & Research Clinical Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521691825001106","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Gastroesophageal reflux disease (GERD) affects 18–28 % of Western populations, with 10–40 % experiencing refractory symptoms despite proton pump inhibitor therapy. We conducted a comprehensive narrative review of dietary interventions in GERD, analyzing studies that measured clinical efficacy through validated symptom scores (GERD-Q, RDQ) and objective reflux parameters (24-h pH-impedance monitoring, acid exposure time). We examined pathophysiological mechanisms, intervention efficacy, and clinical implementation strategies across diverse patient populations. Structured dietary interventions demonstrate clinically meaningful outcomes with robust mechanistic rationale. Low-carbohydrate approaches achieved significant reductions in esophageal acid exposure time (mean difference −2.83 %, 95 % CI: −4.554 to −1.114, p < 0.001), while systematic trigger food elimination protocols achieved 23 % improvement in GERD-Q scores, enabling 45 % of patients to discontinue pharmacological therapy. Plant-based dietary patterns showed remarkable protective effects with 50 % reduction in GERD prevalence (OR = 1.96, 95 % CI 1.22–3.17 for animal food consumption). Weight management interventions demonstrated exceptional efficacy in overweight patients, with GERD prevalence decreasing from 37 % to 15 % (p < 0.01) and 65 % achieving complete symptom resolution. Individual dietary trigger identification achieved high success rates with standardized protocols. Evidence-based dietary interventions offer clinically meaningful alternatives or adjuncts to pharmacological therapy. However, significant study heterogeneity and predominance of short-term trials limit definitive clinical recommendations. Future research should prioritize developing validated precision medicine algorithms integrating clinical phenotyping, genetic markers, and microbiome profiling to optimize personalized dietary prescriptions and investigate long-term sustainability of dietary modifications.
胃食管反流病的非药物治疗:循证饮食和生活方式干预
胃食管反流病(GERD)影响18 - 28%的西方人群,尽管质子泵抑制剂治疗,仍有10 - 40%的人出现难治性症状。我们对饮食干预治疗胃食管反流进行了全面的叙述性回顾,分析了通过有效的症状评分(GERD- q、RDQ)和客观反流参数(24小时ph -阻抗监测、酸暴露时间)测量临床疗效的研究。我们研究了不同患者群体的病理生理机制、干预效果和临床实施策略。结构化饮食干预显示出具有临床意义的结果,具有强大的机制基础。低碳水化合物方法显著减少了食道酸暴露时间(平均差为- 2.83%,95% CI: - 4.554至- 1.114,p < 0.001),而系统触发食物消除方案在GERD-Q评分方面改善了23%,使45%的患者能够停止药物治疗。植物性饮食模式显示出显著的保护作用,可使胃食管反流病患病率降低50% (OR = 1.96,动物性食物的95% CI为1.22-3.17)。体重管理干预在超重患者中表现出特殊的疗效,GERD患病率从37%下降到15% (p < 0.01), 65%的患者症状完全缓解。通过标准化方案,个体饮食诱因识别取得了很高的成功率。循证饮食干预为药物治疗提供了有临床意义的替代或辅助手段。然而,显著的研究异质性和短期试验的优势限制了明确的临床推荐。未来的研究应优先开发经过验证的精准医学算法,整合临床表型、遗传标记和微生物组分析,以优化个性化饮食处方,并研究饮食改变的长期可持续性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。